Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood — Stella

Recruiting

Back to aGVHD trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

United States

Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland, Ohio

Key details

Phase

Safety & dosing

Sponsor

Case Comprehensive Cancer Center

Enrollment target

~36 participants

Started

August 2025

Primary completion

February 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov